Lido Advisors
IDYA icon

Lido Advisors’s IDEAYA Biosciences IDYA Stock Holding History

Lido Advisors’s Portfolio IDYA Stock Details IDYA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$1.91M Sell
51,212
-4,251
-8% -$130K 0.01% 812
2026
Q1 		$1.85M Sell
55,463
-2
-0% -$67 0.01% 736
2025
Q4 		$1.91M Buy
+55,465
New +$1.77M 0.01% 731

Other funds holding IDYA

Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
JT
Jupiter Topco New York $245B AUM
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $717B AUM 35.42% 1-Year Est. Return
BBA
Baker Bros. Advisors New York $20B AUM 154.41% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
LGM
Logos Global Management San Francisco, California $2.32B AUM 536.01% 1-Year Est. Return
Adage Capital Partners
Adage Capital Partners Boston, Massachusetts $71.3B AUM 56.8% 1-Year Est. Return
DM
Deerfield Management New York $9.59B AUM 113.36% 1-Year Est. Return

Lido Advisors's IDYA Position: Q2 2026 in Review

Lido Advisors reduced its IDEAYA Biosciences (IDYA) stake by 7.7% in Q2 2026, selling an estimated $130K and leaving 51,212 shares worth $1.91M. The position accounts for 0.01% of the portfolio, ranked #812.

Lido Advisors first reported a position in IDYA in Q4 2025 and has held it in 3 quarters since. The position peaked at $1.91M in Q4 2025. 286 funds tracked by Wall St. Rank hold IDYA as of Q2 2026.

  • Lido Advisors held 51,212 shares of IDEAYA Biosciences worth $1.91M as of Q2 2026.
  • Lido Advisors sold 4,251 IDEAYA Biosciences shares in Q2 2026, an estimated $130K.
  • IDEAYA Biosciences made up 0.01% of Lido Advisors's portfolio in Q2 2026, its #812 holding.
  • Lido Advisors first reported a position in IDEAYA Biosciences in Q4 2025 and has held it in 3 quarters since.
  • Lido Advisors's IDEAYA Biosciences position peaked at $1.91M in Q4 2025.
  • 286 funds tracked by Wall St. Rank held IDEAYA Biosciences as of Q2 2026.

Based on Lido Advisors's 13F filing for Q2 2026, filed 7 Aug 2026.